← back to search

Kun Bao

Guangzhou University of Chinese Medicine · CN
Area of research
Nephrology · Animal Science and Zoology
Research interest
Research focused on Membranous nephropathy and Kidney disease, with related work in Renal function, Losartan, Meta-analysis. Notable publications include 'A preference-approval structure-based non-additive three-way group consensus decision-making approach for medical diagnosis', 'Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB', and 'Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial'.
h-index
citations
232
works
23
NIH funding
primary concept
email

Recent publications

Study on the diagnostic criteria of syndrome of dampness obstruction in idiopathic membranous nephropathy based on expert consensus.
PubMed 2025cited by 2position: middledoi
Glomerulonephritis, the Most Common Extrahepatic Manifestation Caused by Hepatitis B Virus Infection: Possible Pathogenesis and Therapeutic Approaches
Journal of Medical Virology 2025cited by 0position: middledoi
Multi-modal and multi-criteria conflict analysis model based on deep learning and dominance-based rough sets: Application to clinical non-parallel decision problems
Information Fusion 2024cited by 15position: middledoi
Multi-modal incomplete label information three-way bidirectional decision-making: Applications of disease assessment
Information Fusion 2024cited by 7position: middledoi
Imbalance of T follicular helper cell subsets trigger the differentiation of pathogenic B cells in idiopathic membranous nephropathy
Inflammation Research 2024cited by 6position: middledoi
A rare case of successful treatment of peritoneal dialysis patient with Serratia marcescens peritonitis without catheter removal: case report and literature review
Frontiers in Cellular and Infection Microbiology 2024cited by 5position: middledoi
A preference-approval structure-based non-additive three-way group consensus decision-making approach for medical diagnosis
Information Fusion 2023cited by 48position: lastdoi
Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
Medicine 2023cited by 9position: lastdoi
Identification of hub genes and their correlation with immune infiltrating cells in membranous nephropathy: an integrated bioinformatics analysis
European journal of medical research 2023cited by 9position: lastdoi
The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy ——protocol of a multicenter, randomized control trial (SQ-AUTUMN)
BMC Complementary Medicine and Therapies 2023cited by 4position: lastdoi
Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study
Frontiers in Pharmacology 2022cited by 3position: lastdoi
MO772: Elevated C-Reactive Protein Level and  Vascular Access Failure in End-Stage Renal Disease Patients: A Systematic Review and Meta-Analysis
Nephrology Dialysis Transplantation 2022cited by 1position: middledoi
Identification of biomarkers correlated with IgA nephropathy with co‐expression analysis
Research Square 2022cited by 0position: middledoi
Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
Frontiers in Pharmacology 2021cited by 27position: middledoi
Effectiveness of Chinese herbal medicine combined with Western medicine on deferring dialysis initiation for nondialysis chronic kidney disease stage 5 patients: a multicenter prospective nonrandomized controlled study
Annals of Translational Medicine 2021cited by 11position: middledoi
Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology
American Journal of Nephrology 2021cited by 11position: middledoi
Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB
Biomedicine & Pharmacotherapy 2019cited by 38position: lastdoi
The Bone-Protecting Efficiency of Chinese Medicines Compared With Western Medicines in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Comparative Studies
Frontiers in Pharmacology 2018cited by 16position: middledoi
Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease
BMC Complementary and Alternative Medicine 2015cited by 13position: middledoi
Effects of Tongmai oral liquid in femoral ateriovenous fistula
BMC Complementary and Alternative Medicine 2015cited by 0position: middledoi
Chinese Medicinal Herbs for Childhood Pneumonia: A Systematic Review of Effectiveness and Safety
Evidence-based Complementary and Alternative Medicine 2013cited by 7position: middledoi
Sore throat to patients with IgA nephropathy: traditional Chinese medicine treatment
International Journal of Functional Informatics and Personalised Medicine 2013cited by 0position: middledoi
Discussion on the improvement of the arteriovenous fistula surgeon's micrological technique
2012cited by 0position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Wei Mao · Guangzhou University of Chinese Medicine5 papers (2013–2022)Lijuan Wang · Guangzhou University of Chinese Medicine4 papers (2019–2023)Ping Li · PowerChina (China)4 papers (2022–2023)Chuang Li · South China Agricultural University3 papers (2015–2023)Xusheng Liu · Guangzhou University of Chinese Medicine3 papers (2013–2022)Peiling Su · Guangzhou University of Chinese Medicine3 papers (2012–2015)Xing Liang · Guangzhou Medical University3 papers (2019–2023)Bingzhen Sun · Guangzhou University of Chinese Medicine3 papers (2023–2024)Fuhua Lu · Guangzhou University of Chinese Medicine3 papers (2013–2021)Qizhan Lin · Guangzhou University of Chinese Medicine3 papers (2013–2021)Xiaoli Chu · Sinopec (China)3 papers (2023–2024)Dan Wang · Hubei University of Arts and Science2 papers (2022–2023)Daixin Zhao · Guangzhou University of Chinese Medicine2 papers (2015–2022)Ruimin Tian · Guangzhou University of Chinese Medicine2 papers (2019–2024)Peng Xu · Shandong University2 papers (2019–2022)Xindong Qin · Guangzhou University of Chinese Medicine2 papers (2023–2024)Peng Xu · Guangzhou University of Chinese Medicine2 papers (2015–2024)Xiaofan Hong · Wenzhou Medical University2 papers (2022–2023)Han-guo Peng · Guangzhou University of Chinese Medicine2 papers (2012–2015)Xinfeng Guo · Shandong University2 papers (2015–2022)